Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB.
Proceedings of the National Academy of Sciences of the United States of America2018Yan R, Zhang J, Park HJ, et al.
抄録
cc by 以外（cc by-nc / cc by-nc-nd / NONE 等）は抄録を再掲しない。DOI/PMID へのリンクのみ表示する。
MeSH
AnimalsBrainCaffeineCoffeeDisease Models, AnimalFatty AcidsLewy Body DiseaseMiceMice, Inbred C57BLMice, TransgenicNeuronsNeuroprotectionParkinson DiseasePhosphorylationProtein Phosphatase 2Serotoninalpha-Synuclein
DOI 10.1073/pnas.1813365115
PMID 30509990
原文・出典を見る →